"Antimalarials" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)
| Descriptor ID |
D000962
|
| MeSH Number(s) |
D27.505.954.122.250.100.085
|
| Concept/Terms |
Antimalarials- Antimalarials
- Antimalarial Agents
- Agents, Antimalarial
- Antimalarial Drugs
- Drugs, Antimalarial
- Anti-Malarials
- Anti Malarials
|
Below are MeSH descriptors whose meaning is more general than "Antimalarials".
Below are MeSH descriptors whose meaning is more specific than "Antimalarials".
This graph shows the total number of publications written about "Antimalarials" by people in this website by year, and whether "Antimalarials" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 3 | 0 | 3 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 2 | 4 |
| 2015 | 3 | 1 | 4 |
| 2016 | 2 | 1 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 3 | 0 | 3 |
| 2024 | 2 | 0 | 2 |
| 2025 | 1 | 0 | 1 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antimalarials" by people in Profiles.
-
Malaria in Children at 9 US Hospitals: 2016-2023. Pediatrics. 2026 Jun 01; 157(6).
-
Differential ex vivo susceptibility of Plasmodium malariae and Plasmodium falciparum clinical isolates from Ghana and Mali to current and lead discovery candidate antimalarial drugs. Microbiol Spectr. 2025 Apr; 13(4):e0217624.
-
Post-Artesunate Delayed Hemolysis in Pediatric Malaria Patients in the United States. J Pediatric Infect Dis Soc. 2024 Nov 04; 13(10):533-536.
-
A kalihinol analog disrupts apicoplast function and vesicular trafficking in P. falciparum malaria. Science. 2024 09 27; 385(6716):eadm7966.
-
Malaria: A focused review for the emergency medicine clinician. Am J Emerg Med. 2024 03; 77:7-16.
-
Nonclassical mechanisms to irreversibly suppress ?-hematin crystal growth. Commun Biol. 2023 07 27; 6(1):783.
-
Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana. Microbiol Spectr. 2023 06 15; 11(3):e0491622.
-
Hypnozoite depletion in successive Plasmodium vivax relapses. PLoS Negl Trop Dis. 2022 07; 16(7):e0010648.
-
Inhibiting protein synthesis to treat malaria. Science. 2022 06 03; 376(6597):1049-1050.
-
Development and Validation of an In Silico Decision Tool To Guide Optimization of Intravenous Artesunate Dosing Regimens for Severe Falciparum Malaria Patients. Antimicrob Agents Chemother. 2021 05 18; 65(6).